Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2025-12-30 @ 1:20 PM
Study NCT ID:
NCT03978832
Status:
COMPLETED
Last Update Posted:
2021-07-07
First Post:
2019-05-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone
Sponsor:
Indivior Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-28
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-05-12
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-30
First Submit QC Date:
None
Study First Post Date:
2019-06-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-04-26
Results First Submit QC Date:
None
Results First Post Date:
2021-07-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-13
Last Update Post Date:
2021-07-07
Last Update Post Date Type:
ACTUAL